Metis TechBio company profile

7666 · HKEX · HKD

Compare Metis TechBio
$6.65Change from previous close: −9.53%Absolute change: −$0.70

Close · November 20, 2026

Company profile

Metis TechBio has 150 employees and is headquartered in Beijing, China.

Metis TechBio develops AI-driven nanomaterial tools for delivering active agents across carbon-based life forms, with research work in Chinese Mainland and the United States. Its NanoForge suite pairs a lipid compound collection with machine-learning models, molecular simulation and automated screening systems. Further platforms named AiTEM, AiLNP and AiRNA model how nanoscale particles interact, supporting the design, optimization and validation of nanomaterials and their payloads. Customers include pharmaceutical companies, biotechnology firms and medical research institutions, and the company was formerly named Hangzhou Jitai Pharmaceutical Technology.

In the fiscal year ended December 2025, revenue was 105 million yuan and the net loss reached 391.8 million yuan. The company employs 150 people and is headquartered in Beijing, where it was incorporated in 2020. It has a strategic partnership with Eli Lilly and Company.

Company facts

Sector
Materials
Industry
Biotechnology
Headquarters
Room 201, 2/F, Building 13, Beijing
Employees
150
Chief executive
Tsai-Ta Lai
Founded
2020
Fiscal year
January - December
Listing
7666 · HKEX
Currency
HKD
ISIN
CNE100007LD1

Metis TechBio and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
Metis TechBio7666Hong Kong SAR China$1.11B150-131.2%—
MesoblastMSBAustralia$1.48B108-42.6%—
Neuren PharmaceuticalsNEUAustralia$1.83B819.9%144.0
InSilico Medicine Cayman TopCo3696Hong Kong SAR China$2.59B333-6.9%—
Telix PharmaceuticalsTLXAustralia$2.92B1,1206.2%92.3
3SBio1530Hong Kong SAR China$4.56B6,06860.3%3.90

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Metis TechBio with its competitors